![Kinneret Livnat Savitsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kinneret Livnat Savitsky
Direktor/Vorstandsmitglied bei Biomica Ltd.
Aktive Positionen von Kinneret Livnat Savitsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Kinneret Livnat Savitsky
Ehemalige bekannte Positionen von Kinneret Livnat Savitsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | 10.05.2018 | - |
Statistik
International
Israel | 3 |
Operativ
Director/Board Member | 2 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |